
The day after the Fed hike 9/22/22
CNBC's "Fast Money"
00:00
The Elsheimer's Drug Is the Holy Grail
The elsheimer's drug, while while it could be promising, is not at all within the model. And so i think buying it in front of the release and maybe selling it on the release, we'll see that early next year. Rit coming up getting blocked, shares of the payment company sinking as analysts lose interests in the move; option traders piling in. Got the details next.
Play episode from 38:49
Transcript


